Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

7.93
Delayed Data
As of May 05
 -0.09 / -1.12%
Today’s Change
5.57
Today|||52-Week Range
11.05
-26.51%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Revenue and IncomeNet Revenues0.00711.0K33.8M31.6M
 
 
 
 
Depreciation And Amortization160.0K161.0K184.0K189.0K
 
 
 
 
 
 
Operating ExpensesGross Income-160.0K------
 
 
General Expenses19.3M29.9M16.9M15.0M
 
 
 
 
 
Research And Development15.2M20.0M12.2M9.8M
 
 
 
 
 
Total Operating Expenses19.5M30.1M17.1M15.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-19.5M-29.4M16.7M16.4M
 
 
 
 
 
Interest Expense On Debt16.0K15.0K12.0K13.0K
 
 
 
 
 
Other Expenses0.000.008.9M0.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-19.3M-29.2M26.0M16.8M
 
 
 
 
 
Income Taxes-70.0K-185.0K-245.0K-140.0K
 
 
 
 
 
Net Income-19.3M-29.0M26.3M17.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS111.2M117.8M136.4M136.6M
 
 
 
 
 
Shares To Calculate EPS Diluted111.2M117.8M140.0M140.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.17-$0.25$0.19$0.12
 
 
 
 
 
EPS Diluted-$0.17-$0.25$0.19$0.12